Have a personal or library account? Click to login
High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer Cover

High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer

Open Access
|Jun 2017

Authors

Takashi Ono

abc1123513@gmail.com

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan

Tomonori Yabuuchi

Department of Radiation Oncology, Ninohe Hospital, Iwate, Japan

Tatsuya Nakamura

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan

Kanako Kimura

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan

Yusuke Azami

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan

Katsumi Hirose

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan

Motohisa Suzuki

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan

Hitoshi Wada

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan

Yasuhiro Kikuchi

Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan

Kenji Nemoto

Department of Radiation Oncology, Yamagata University Faculty of Medicine, Yamagata, Japan
DOI: https://doi.org/10.1515/raon-2017-0023 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 324 - 330
Submitted on: Jan 17, 2017
|
Accepted on: May 14, 2017
|
Published on: Jun 16, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Takashi Ono, Tomonori Yabuuchi, Tatsuya Nakamura, Kanako Kimura, Yusuke Azami, Katsumi Hirose, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Kenji Nemoto, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.